Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BREADS: Low-Carb Diet in Breast Cancer
NCT04189263Phase 2Terminated
- Start
- Feb 2020
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms). Primary endpoint: Mean change in weight at 6 months. Started Feb 2020; status: terminated.
Beyond the preview
Go deeper on NCT04189263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189263.